Skip to Main Content (Press Enter)

Logo UNILINK
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture

UNI-FIND
Logo UNILINK

|

UNI-FIND

unilink.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  1. Pubblicazioni

EXPERT OPINION ON DRUG SAFETY

Rivista
Codice:
E184752
ISSN:
1474-0338
  • Dati Generali

Dati Generali

Pubblicazioni (12)

  • ascendente
  • decrescente
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs
Articolo
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions
Articolo
Hepatobiliary disorders and Direct-Acting Antiviral (DAA) therapies: real-world evidence and insights from the EudraVigilance database
Articolo
Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 monoclonal antibodies: a systematic review and meta-analysis of observational studies
Articolo
Hypogammaglobulinemia in patients with multiple sclerosis receiving disease modifying therapies: disproportionality analysis using the EudraVigilance database
Articolo
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy
Articolo
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs)
Articolo
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system?
Articolo
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance
Articolo
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS)
Articolo
The risk of fractures, acute myocardial infarction, atrial fibrillation and ventricular arrhythmia in geriatric patients exposed to promethazine
Articolo
The safety of sublingual immunotherapy, can the rare systemic reactions be prevented?
Articolo
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} di {itemsNumber}
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.6.0.0